Login

Join for Free!
16607 members
Home Forum Dictionary Articles Tutorials Books Directory Share your work
table of contents table of contents

In this report, by inclusion of multiple components of the HIV genome, …

Biology Articles » Virology » Rev-dependent lentiviral expression vector » References

References
- Rev-dependent lentiviral expression vector

  1. Felber BK, Pavlakis GN: A Quantitative Bioassay for Hiv-1 Based on Trans-Activation.

    Science 1988, 239(4836):184-187.

  2. Schwartz S, Felber BK, Fenyo EM, Pavlakis GN: Rapidly and Slowly Replicating Human Immunodeficiency Virus Type-1 Isolates Can Be Distinguished According to Target-Cell Tropism in T-Cell and Monocyte Cell-Lines.

    Proc Natl Acad Sci U S A 1989, 86(18):7200-7203.

  3. Rocancourt D, Bonnerot C, Jouin H, Emerman M, Nicolas JF: Activation of a Beta-Galactosidase Recombinant Provirus - Application to Titration of Human-Immunodeficiency-Virus (Hiv) and Hiv-Infected Cells.

    J Virol 1990, 64(6):2660-2668.

  4. Kimpton J, Emerman M: Detection of Replication-Competent and Pseudotyped Human-Immunodeficiency-Virus with a Sensitive Cell-Line on the Basis of Activation of an Integrated Beta-Galactosidase Gene.

    Journal of Virology 1992, 66(4):2232-2239.

  5. Muesing MA, Smith DH, Capon DJ: Regulation of Messenger-Rna Accumulation by a Human-Immunodeficiency-Virus Transactivator Protein.

    Cell 1987, 48(4):691-701.

  6. Dingwall C, Ernberg I, Gait MJ, Green SM, Heaphy S, Karn J, Lowe AD, Singh M, Skinner MA, Valerio R: Human Immunodeficiency Virus-1 Tat Protein Binds Trans-Activation-Responsive Region (Tar) Rna Invitro.

    Proceedings of the National Academy of Sciences of the United States of America 1989, 86(18):6925-6929.

  7. Berkhout B, Silverman RH, Jeang KT: Tat Trans-Activates the Human Immunodeficiency Virus through a Nascent Rna Target.

    Cell 1989, 59(2):273-282.

  8. Kao SY, Calman AF, Luciw PA, Peterlin BM: Anti-Termination of Transcription within the Long Terminal Repeat of Hiv-1 by Tat Gene-Product.

    Nature 1987, 330(6147):489-493.

  9. Laspia MF, Rice AP, Mathews MB: Hiv-1 Tat Protein Increases Transcriptional Initiation and Stabilizes Elongation.

    Cell 1989, 59(2):283-292.

  10. Kato H, Sumimoto H, Pognonec P, Chen CH, Rosen CA, Roeder RG: Hiv-1 Tat Acts as a Processivity Factor Invitro in Conjunction with Cellular Elongation-Factors.

    Genes & Development 1992, 6(4):655-666.

  11. Raha T, Cheng SWG, Green MR: HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.

    Plos Biology 2005, 3(2):221-230.

  12. Brady J, Kashanchi F: Tat gets the "green" light on transcription initiation.

    Retrovirology 2005., 2:

  13. Jordan A, Defechereux P, Verdin E: The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation.

    Embo Journal 2001, 20(7):1726-1738.

  14. Gervaix A, West D, Leoni LM, Richman DD, WongStaal F, Corbeil J: A new reporter cell line to monitor HIV infection and drug susceptibility in vitro.

    Proceedings of the National Academy of Sciences of the United States of America 1997, 94(9):4653-4658.

  15. Feinberg MB, Jarrett RF, Aldovini A, Gallo RC, Wongstaal F: Htlv-Iii Expression and Production Involve Complex Regulation at the Levels of Splicing and Translation of Viral-Rna.

    Cell 1986, 46(6):807-817.

  16. Malim MH, Hauber J, Fenrick R, Cullen BR: Immunodeficiency Virus Rev Trans-Activator Modulates the Expression of the Viral Regulatory Genes.

    Nature 1988, 335(6186):181-183.

  17. Emerman M, Vazeux R, Peden K: The Rev Gene-Product of the Human Immunodeficiency Virus Affects Envelope-Specific Rna Localization.

    Cell 1989, 57(7):1155-1165.

  18. Robertguroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS: Structure and Expression of Tat-Specific, Rev-Specific, and Nef-Specific Transcripts of Human-Immunodeficiency-Virus Type-1 in Infected Lymphocytes and Macrophages.

    Journal of Virology 1990, 64(7):3391-3398.

  19. Purcell DFJ, Martin MA: Alternative Splicing of Human-Immunodeficiency-Virus Type-1 Messenger-Rna Modulates Viral Protein Expression, Replication, and Infectivity.

    Journal of Virology 1993, 67(11):6365-6378.

  20. Kim SY, Byrn R, Groopman J, Baltimore D: Temporal Aspects of DNA and Rna-Synthesis During Human Immunodeficiency Virus-Infection - Evidence for Differential Gene-Expression.

    Journal of Virology 1989, 63(9):3708-3713.

  21. Klotman ME, Kim S, Buchbinder A, Derossi A, Baltimore D, Wongstaal F: Kinetics of Expression of Multiply Spliced Rna in Early Human-Immunodeficiency-Virus Type-1 Infection of Lymphocytes and Monocytes.

    Proceedings of the National Academy of Sciences of the United States of America 1991, 88(11):5011-5015.

  22. Sodroski J, Goh WC, Rosen C, Dayton A, Terwilliger E, Haseltine W: A 2nd Posttranscriptional Transactivator Gene Required for Htlv-Iii Replication.

    Nature 1986, 321(6068):412-417.

  23. Knight DM, Flomerfelt FA, Ghrayeb J: Expression of the Art Trs Protein of Hiv and Study of Its Role in Viral Envelope Synthesis.

    Science 1987, 236(4803):837-840.

  24. Schwartz S, Campbell M, Nasioulas G, Harrison J, Felber BK, Pavlakis GN: Mutational Inactivation of an Inhibitory Sequence in Human-Immunodeficiency-Virus Type-1 Results in Rev-Independent Gag Expression.

    Journal of Virology 1992, 66(12):7176-7182.

  25. Kotsopoulou E, Kim VN, Kingsman AJ, Kingsman SM, Mitrophanous KA: A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene.

    Journal of Virology 2000, 74(10):4839-4852.

  26. Hope TJ, Huang XJ, McDonald D, Parslow TG: Steroid-Receptor Fusion of the Human-Immunodeficiency-Virus Type-1 Rev Transactivator - Mapping Cryptic Functions of the Arginine-Rich Motif.

    Proceedings of the National Academy of Sciences of the United States of America 1990, 87(19):7787-7791.

  27. Ragheb JA, Bressler P, Daucher M, Chiang L, Chuah MKL, Vandendriessche T, Morgan RA: Analysis of Transdominant Mutants of the Hiv Type-1 Rev Protein for Their Ability to Inhibit Rev Function, Hiv Type-1 Replication, and Their Use as Anti-Hiv Gene Therapeutics.

    Aids Research and Human Retroviruses 1995, 11(11):1343-1353.

  28. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

    Science 1996, 272(5259):263-267.

  29. He JL, Choe S, Walker R, Dimarzio P, Morgan DO, Landau NR: Human-Immunodeficiency-Virus Type-1 Viral-Protein-R (Vpr) Arrests Cells in the G(2) Phase of the Cell-Cycle by Inhibiting P34(Cdc2) Activity.

    Journal of Virology 1995, 69(11):6705-6711.

  30. Henderson AJ, Calame KL: CCAAT/enhancer binding protein (C/EBP) sites are required for HIV-1 replication in primary macrophages but not CD4(+) T cells.

    Proceedings of the National Academy of Sciences of the United States of America 1997, 94(16):8714-8719.

  31. Lee ES, Sarma D, Zhou HY, Henderson AJ: CCAAT/enhancer binding proteins are not required for HIV-1 entry but regulate proviral transcription by recruiting coactivators to the long-terminal repeat in monocytic cells.

    Virology 2002, 299(1):20-31.

  32. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE: Cytoplasmic Assembly and Accumulation of Human Immunodeficiency Virus Type-1 and Type-2 in Recombinant Human Colony-Stimulating Factor-1-Treated Human-Monocytes - an Ultrastructural-Study.

    Journal of Virology 1988, 62(8):2578-2586.

  33. Pelchen-Matthews A, Kramer B, Marsh M: Infectious HIV-1 assembles in late endosomes in primary macrophages.

    Journal of Cell Biology 2003, 162(3):443-455.

  34. Bagasra O, Hauptman SP, Lischner HW, Sachs M, Pomerantz RJ: Detection of Human-Immunodeficiency-Virus Type-1 Provirus in Mononuclear-Cells by Insitu Polymerase Chain-Reaction.

    New England Journal of Medicine 1992, 326(21):1385-1391.

  35. Patterson BK, Till M, Otto P, Goolsby C, Furtado MR, McBride LJ, Wolinsky SM: Detection of Hiv-1 DNA and Messenger-Rna in Individual Cells by Pcr-Driven Insitu Hybridization and Flow-Cytometry.

    Science 1993, 260(5110):976-979.

  36. Embretson J, Zupancic M, Beneke J, Till M, Wolinsky S, Ribas JL, Burke A, Haase AT: Analysis of Human Immunodeficiency Virus-Infected Tissues by Amplification and Insitu Hybridization Reveals Latent and Permissive Infections at Single-Cell Resolution.

    Proceedings of the National Academy of Sciences of the United States of America 1993, 90(1):357-361.

  37. Nara PL, Hatch WC, Dunlop NM, Robey WG, Arthur LO, Gonda MA, Fischinger PJ: Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing Antibody.

    Aids Research and Human Retroviruses 1987, 3(3):283-302.

  38. Perez VL, Rowe T, Justement JS, Butera ST, June CH, Folks TM: An Hiv-1-Infected T-Cell Clone Defective in Il-2 Production and Ca2+ Mobilization after Cd3 Stimulation.

    Journal of Immunology 1991, 147(9):3145-3148.

  39. Theodore TS, Englund G, BucklerWhite A, Buckler CE, Martin MA, Peden KWC: Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions.

    Aids Research and Human Retroviruses 1996, 12(3):191-194.

  40. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of Acquired Immunodeficiency Syndrome-Associated Retrovirus in Human and Nonhuman Cells Transfected with an Infectious Molecular Clone.

    Journal of Virology 1986, 59(2):284-291.

  41. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK: Vesicular Stomatitis-Virus G Glycoprotein Pseudotyped Retroviral Vectors - Concentration to Very High-Titer and Efficient Gene-Transfer into Mammalian and Nonmammalian Cells.

    Proceedings of the National Academy of Sciences of the United States of America 1993, 90(17):8033-8037.

  42. Reed LJ, Muench H: A simple method of estimating fifty percent endpoints.

    American Journal of Hygiene 1938, 27(3):493-497.

  43. Chesebro B, Wehrly K, Nishio J, Perryman S: Macrophage-Tropic Human-Immunodeficiency-Virus Isolates from Different Patients Exhibit Unusual V3 Envelope Sequence Homogeneity in Comparison with T-Cell-Tropic Isolates - Definition of Critical Amino-Acids Involved in Cell Tropism.

    Journal of Virology 1992, 66(11):6547-6554.

  44. Wehrly K, Chesebro B: p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents.

    Methods-a Companion to Methods in Enzymology 1997, 12(4):288-293.

  45. Toohey K, Wehrly K, Nishio J, Perryman S, Chesebro B: Human-Immunodeficiency-Virus Envelope V1 and V2 Regions Influence Replication Efficiency in Macrophages by Affecting Virus Spread.

    Virology 1995, 213(1):70-79.


rating: 0.00 from 0 votes | updated on: 8 May 2008 | views: 223 |

share this article | email to friends

suggest a revision
print this page
print the whole article

Rate article:







excellent!bad…